µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼ : ¾à¹° À¯Çüº°, Åõ¿© °æ·Îº°, ¿ëµµº°, µ¿¹° À¯Çüº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)
Animal Sedatives Market Share, Size, Trends, Industry Analysis Report, By Drug Class; By Route of Administration; By Application (Diagnosis, Surgery, Others); By Animal Type; By Region; Segment Forecast, 2024- 2032
»óǰÄÚµå
:
1424095
¸®¼Ä¡»ç
:
Polaris Market Research
¹ßÇàÀÏ
:
2024³â 01¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 118 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 2¾ï 4,725¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¶»ç º¸°í¼´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.
À̸Ó¡ ¸¶ÄÏÀÇ °æÁ¦ ¼ºÀåÀº µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå¿¡ Å« ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ºÎÀ¯ÇØÁü¿¡ µû¶ó ÀÌµé ½ÃÀå¿¡¼´Â ¹Ý·Áµ¿¹° ¼ÒÀ¯°¡ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ¼öÀÇÇп¡ ´ëÇÑ °ü½Éµµ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. °¡Ã³ºÐ ¼ÒµæÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¹Ý·Áµ¿¹° ¼ÒÀ¯ÁÖµéÀº µ¿¹°ÀÇ ÀÇ·á °³ÀÔ¿¡ ÁøÁ¤Á¦¸¦ »ç¿ëÇÏ´Â µîÀÇ Á¾ÇÕÀûÀÎ °Ç° °ü¸®¿¡ ÅõÀÚÇÏ°Ô µË´Ï´Ù. µ¿½Ã¿¡ Ãà»ê¹°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ ¹è°æÀ¸·Î ÇÑ Ãà»ê¾÷ÀÇ È®ÀåÀº °¡ÃàÀÇ °ü¸® ¹× Ãë±Þ¿¡ ÁøÁ¤Á¦ÀÇ È°·Î¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °æÁ¦ ¼ºÀåÀº ¼öÀÇÇÐ ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁõÆø½Ãų »Ó¸¸ ¾Æ´Ï¶ó Çõ½ÅÀûÀ̰í È¿°úÀûÀÎ ÁøÁ¤ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ôÀº ȯ°æÀ» Á¶¼ºÇÏ¿© µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀåÀÇ ÀÌÇØ °ü°èÀڵ鿡°Ô À¯¸®ÇÑ Àü¸ÁÀ» Á¦½ÃÇÕ´Ï´Ù.
º¸Çè Àû¿ëÀ» ¼±ÅÃÇÏ´Â º¸È£ÀÚ°¡ ´Ã¾î³²¿¡ µû¶ó, ÁøÁ¤Á¦¸¦ ÇÊ¿ä·Î ÇÏ´Â ½Ã¼úÀ» Æ÷ÇÔÇÑ Á¾ÇÕÀûÀÎ ¼öÀÇÇÐ Ä¡·á°¡ ´«¿¡ ¶ç°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° º¸ÇèÀº Ã¥ÀÓ°¨ ÀÖ´Â ¹Ý·Áµ¿¹° ¾çÀ°À» Àå·ÁÇϰí, ¹Ý·Áµ¿¹°ÀÇ ´Ù¾çÇÑ Ä¡·á¿¡¼ ÁøÁ¤Á¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ¹Ý·Áµ¿¹°ÀÇ ÃÖÀûÀÇ °Ç° °ü¸®¸¦ ÃËÁøÇÒ »Ó¸¸ ¾Æ´Ï¶ó, ½ºÆ®·¹½º ¾øÀÌ Æí¾ÈÇÑ ÀÇ·á °æÇèÀ» º¸ÀåÇÏ´Â ÁøÁ¤Á¦ÀÇ ¿ªÇÒÀ» °ÈÇϰí ÀÖ½À´Ï´Ù.
¾à¹° Àü´Þ ±â¼úÀÇ ¹ßÀüÀº µ¿¹° ÀÇ·á¿¡¼ ÁøÁ¤Á¦ÀÇ È¿°ú, ¾ÈÀü¼º ¹× Åõ¿©¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. »õ·Î¿î Á¦ÇüµéÀÌ µîÀåÇÏ¸é¼ ÁøÁ¤Á¦ ¼öÁØÀ» Á¤È®ÇÏ°Ô Á¶ÀýÇϰí, ¾àÈ¿¸¦ ºü¸£°Ô ¹ßÇö½Ã۸ç, ºÎÀÛ¿ëÀ» ÁÙÀÏ ¼ö ÀÖ´Â »õ·Î¿î Á¦ÇüÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº ¼öÀÇ»çÀÇ Àü¹ÝÀûÀÎ »ç¿ë ÆíÀǼºÀ» Çâ»ó½Ã۰í ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
º¸´Ù Á¤±³Çϰí È¿À²ÀûÀÎ ¾à¹° Àü´Þ ½Ã½ºÅÛÀÇ °³¹ß·Î ÀÎÇØ ´Ù¾çÇÑ µ¿¹° Á¾ÀÇ °íÀ¯ÇÑ ¿ä±¸¿¡ ¸Â´Â °í±Þ ÁøÁ¤Á¦ ¼Ö·ç¼Ç µµÀÔ °¡´É¼ºÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Á¦¾àȸ»ç¿Í ÀÌÇØ°ü°èÀÚµéÀº ÁøÈÇÏ´Â ¼öÀÇÇÐÀû ¿ä±¸»çÇ׿¡ ´ëÀÀÇϱâ À§ÇØ ÀÌ·¯ÇÑ ±â¼úÀû Çõ½ÅÀ» Ȱ¿ëÇÏ¿© µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀåÀÇ ¼ºÀå°ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
2023³â, Æä³ëƼ¾ÆÁø °è¿Àº ÁøÁ¤ È¿°úÀÇ ÀÔÁõ, ´Ù¾çÇÑ ¿ëµµ, ±ä ÀÛ¿ë ½Ã°£À¸·Î ÀÎÇØ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
2023³â ºñ°æ±¸ ÀǾàǰ ºÎ¹®Àº ÀÇ·á ½Ã¼ú, ¼ö¼ú ¹× ¿µ»ó Áø´Ü¿¡ Àû¿ëµÇ¾î Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
2023³â, ¼ö¼ú ºÎ¹®Àº ¼ö¼ú ÀüÀÇ Æò¿ÂÇÔ, ½ºÆ®·¹½º ÃÖ¼ÒÈ, µ¿¹°ÀÇ ¼ö¼ú Á¶°Ç °³¼±À¸·Î ÀÎÇØ ¼ö¼ú ºÎ¹®ÀÌ Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
2023³â, ¹Ý·Áµ¿¹° ¾çÀ° Áõ°¡¿Í ¹Ý·Áµ¿¹° ºÒ¾È°¨ °¨¼Ò·Î ÀÎÇØ ¼Òµ¿¹° ºÎ¹®ÀÌ Å« ¸ÅÃâ ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
2023³â¿¡´Â ºÏ¹Ì°¡ ±âÁ¸ ±â¾÷, ¹Ý·Áµ¿¹° »çÀ° Áõ°¡, Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü ¹× ¿¬±¸ °³¹ß·Î ÀÎÇØ ¼¼°è ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.
½ÃÀå¿¡´Â Aspen Pharmacare, Bayer Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Dekra Pharmaceuticals, Elanco Animal Health, Virbac, Zoetis µî ¼¼°è ½ÃÀå ±â¾÷µéÀÇ Á¸Àç·Î ÀÎÇØ °æÀïÀÌ Ä¡¿ÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå ¼¼°èÀÇ µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå ÀλçÀÌÆ®
µ¿¹°¿ë ÁøÁ¤Á¦ - ¾÷°è ÇöȲ
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀΰú ±âȸ
¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
PESTLE ºÐ¼®
µ¿¹°¿ë ÁøÁ¤Á¦ ¾÷°è µ¿Çâ
¹ë·ùüÀÎ ºÐ¼®
COVID-19ÀÇ ¿µÇ⠺м®
Á¦5Àå ¼¼°èÀÇ µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, Åõ¿© °æ·Îº°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
ºñ°æ±¸
°æ±¸
Á¦6Àå ¼¼°èÀÇ µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, ¿ëµµº°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
Áø´Ü
¼ö¼ú
±âŸ
Á¦7Àå ¼¼°èÀÇ µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, ¾àÁ¦ Ŭ·¡½ºº°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
Benzodiazepines
Butyrophenones
Phenothiazines
Alpha-2 Adrenergic Receptor Agonists
±âŸ
Á¦8Àå ¼¼°èÀÇ µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, µ¿¹° À¯Çüº°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
¼ÒÇü
´ëÇü
Á¦9Àå ¼¼°èÀÇ µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, Áö¿ªº°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå Æò°¡, Áö¿ªº°, 2019-2032³â
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ºÏ¹Ì
ºÏ¹Ì : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032³â
ºÏ¹Ì : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, µ¿¹° À¯Çüº°, 2019-2032³â
ºÏ¹Ì : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, ¿ëµµº°, 2019-2032³â
ºÏ¹Ì : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, ¾àÁ¦ Ŭ·¡½ºº°, 2019-2032³â
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ¹Ì±¹
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ij³ª´Ù
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - À¯·´
À¯·´ : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032³â
À¯·´ : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, µ¿¹° À¯Çüº°, 2019-2032³â
À¯·´ : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, ¿ëµµº°, 2019-2032³â
À¯·´ : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, ¾àÁ¦ Ŭ·¡½ºº°, 2019-2032³â
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ¿µ±¹
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ÇÁ¶û½º
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - µ¶ÀÏ
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ÀÌÅ»¸®¾Æ
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ½ºÆäÀÎ
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ³×´ú¶õµå
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ·¯½Ã¾Æ
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
¾Æ½Ã¾ÆÅÂÆò¾ç : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032³â
¾Æ½Ã¾ÆÅÂÆò¾ç : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, µ¿¹° À¯Çüº°, 2019-2032³â
¾Æ½Ã¾ÆÅÂÆò¾ç : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, ¿ëµµº°, 2019-2032³â
¾Æ½Ã¾ÆÅÂÆò¾ç : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, ¾àÁ¦ Ŭ·¡½ºº°, 2019-2032³â
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - Áß±¹
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - Àεµ
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ÀϺ»
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ¸»·¹À̽þÆ
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - Àεµ³×½Ã¾Æ
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - Çѱ¹
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032³â
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, µ¿¹° À¯Çüº°, 2019-2032³â
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, ¿ëµµº°, 2019-2032³â
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, ¾àÁ¦ Ŭ·¡½ºº°, 2019-2032³â
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - À̽º¶ó¿¤
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
¶óƾ¾Æ¸Þ¸®Ä« : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032³â
¶óƾ¾Æ¸Þ¸®Ä« : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, µ¿¹° À¯Çüº°, 2019-2032³â
¶óƾ¾Æ¸Þ¸®Ä« : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, ¿ëµµº°, 2019-2032³â
¶óƾ¾Æ¸Þ¸®Ä« : µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå, ¾àÁ¦ Ŭ·¡½ºº°, 2019-2032³â
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ¸ß½ÃÄÚ
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ºê¶óÁú
µ¿¹°¿ë ÁøÁ¤Á¦ ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª
Á¦10Àå °æÀï ±¸µµ
È®Àå ¹× Àμö ºÐ¼®
Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³
Á¦11Àå ±â¾÷ °³¿ä
Aspen Pharmacare
Bayer Animal Health
Bimeda Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Chanelle Pharma
Dechra Pharmaceuticals
Elanco Animal Health
Orion Corporation
Neogen Corporation
Norbrook Laboratories
Troy Laboratories
Vetoquinol
Virbac
Zoetis
LSH
¿µ¹® ¸ñÂ÷
The global Animal Sedatives market size is expected to reach USD 247.25 million by 2032, according to a new study by Polaris Market Research. The report "Animal Sedatives Market Share, Size, Trends, Industry Analysis Report, By Drug Class; By Route of Administration; By Application (Diagnosis, Surgery, Others); By Animal Type; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The economic growth in emerging markets creates substantial opportunities in the animal sedatives market. With increasing affluence, these markets witness a surge in pet ownership and a heightened focus on veterinary care. Growing disposable incomes empower pet owners to invest in comprehensive healthcare, including the use of sedatives for animal medical interventions. Simultaneously, the expansion of livestock farming, driven by escalating demand for animal products, provides avenues for sedatives in managing and handling farm animals. This economic growth not only amplifies the demand for veterinary services but also fosters an environment where innovative and effective sedative solutions are in high demand, presenting lucrative prospects for stakeholders in the animal sedative market.
As more pet owners opt for insurance coverage, there is a notable increase in comprehensive veterinary care, including procedures requiring sedation. Pet insurance policies incentivize responsible pet ownership, driving a heightened demand for sedatives in various interventions for companion animals. This trend not only promotes optimal healthcare for pets but also enhances the role of sedatives in ensuring stress-free and comfortable medical experiences.
Advances in drug delivery technologies are revolutionizing the efficacy, safety, and administration of sedatives in veterinary care. Novel formulations that offer precise control over sedation levels, rapid onset of action, and reduced side effects are becoming feasible. These innovations enhance the overall ease of use for veterinary practitioners and contribute to improved patient outcomes.
With the development of more targeted and efficient drug delivery systems, there is a growing potential for the introduction of advanced sedative solutions tailored to the specific needs of diverse animal species. Pharmaceutical companies and stakeholders are leveraging these technological breakthroughs to address evolving veterinary requirements, fostering growth and innovation in the animal sedatives market.
Animal Sedatives Market Report Highlights
In 2023, the phenothiazines segment accounted for significant market share owing to proven calming effect, versatility in applications, and prolonged duration of action.
In 2023, the parenteral segment accounted for significant market share owing to applications in medical procedures, surgeries, or diagnostic imaging.
In 2023, the surgery segment held significant revenue share owing to preoperative calmness, minimized stress, and improved surgical conditions for animals.
In 2023, the small animal segment held significant revenue share owing to growing pet ownership, and anxiety reduction in pets.
In 2023, North America region dominated the global market due to established players, rise in pet ownership, ongoing technological advancements, and research and development.
The market is highly competitive owing to the existence of market players with a global presence, including Aspen Pharmacare, Bayer Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Dechra Pharmaceuticals, Elanco Animal Health, Virbac, and Zoetis among others.
Polaris Market Research has segmented the Animal Sedatives market report based on drug class, route of administration, application, animal type, and region:
Animal Sedatives, Drug Class Outlook (Revenue - USD Million, 2019 - 2032)
Benzodiazepines
Butyrophenones
Phenothiazines
Alpha-2 Adrenergic Receptor Agonists
Others
Animal Sedatives, Route of Administration Outlook (Revenue - USD Million, 2019 - 2032)
Animal Sedatives, Application Outlook (Revenue - USD Million, 2019 - 2032)
Animal Sedatives, Animal Type Outlook (Revenue - USD Million, 2019 - 2032)
Animal Sedatives, Regional Outlook (Revenue - USD Million, 2019 - 2032)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Netherlands
Spain
Russia
Asia Pacific
Japan
China
India
Malaysia
Indonesia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Table of Contents
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
3. Research Methodology
3.1. Overview
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Animal Sedatives Market Insights
4.1. Animal Sedatives - Industry Snapshot
4.2. Animal Sedatives Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Technological advancement
4.2.1.2. Increasing use of Animal Sedatives technology in healthcare
4.2.2. Restraints and Challenges
4.2.2.1. Increasing digitization will restrict the market growth
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Animal Sedatives Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Animal Sedatives Market, by Route of Administration
5.1. Key Findings
5.2. Introduction
5.2.1. Global Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
5.3. Parenteral
5.3.1. Global Animal Sedatives Market, by Parenteral, by Region, 2019-2032 (USD Million)
5.4. Oral
5.4.1. Global Animal Sedatives Market, by Oral, by Region, 2019-2032 (USD Million)
6. Global Animal Sedatives Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. Global Animal Sedatives Market, by Application, 2019-2032 (USD Million)
6.3. Diagnosis
6.3.1. Global Animal Sedatives Market, by Diagnosis, by Region, 2019-2032 (USD Million)
6.4. Surgery
6.4.1. Global Animal Sedatives Market, by Surgery, by Region, 2019-2032 (USD Million)
6.5. Others
6.5.1. Global Animal Sedatives Market, by Others, by Region, 2019-2032 (USD Million)
7. Global Animal Sedatives Market, by Drug Class
7.1. Key Findings
7.2. Introduction
7.2.1. Global Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
7.3. Benzodiazepines
7.3.1. Global Animal Sedatives Market, by Benzodiazepines, by Region, 2019-2032 (USD Million)
7.4. Butyrophenones
7.4.1. Global Animal Sedatives Market, by Butyrophenones, by Region, 2019-2032 (USD Million)
7.5. Phenothiazines
7.5.1. Global Animal Sedatives Market, by Phenothiazines, by Region, 2019-2032 (USD Million)
7.6. Alpha-2 Adrenergic Receptor Agonists
7.6.1. Global Animal Sedatives Market, by Alpha-2 Adrenergic Receptor Agonists, by Region, 2019-2032 (USD Million)
7.7. Others
7.7.1. Global Animal Sedatives Market, by Others, by Region, 2019-2032 (USD Million)
8. Global Animal Sedatives Market, by Animal Type
8.1. Key Findings
8.2. Introduction
8.2.1. Global Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
8.3. Small
8.3.1. Global Animal Sedatives Market, by Small, by Region, 2019-2032 (USD Million)
8.4. Large
8.4.1. Global Animal Sedatives Market, by Large, by Region, 2019-2032 (USD Million)
9. Global Animal Sedatives Market, by Geography
9.1. Key findings
9.2. Introduction
9.2.1. Animal Sedatives Market Assessment, By Geography, 2019-2032 (USD Million)
9.3. Animal Sedatives Market - North America
9.3.1. North America: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.3.2. North America: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.3.3. North America: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.3.4. North America: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.3.5. Animal Sedatives Market - U.S.
9.3.5.1. U.S.: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.3.5.2. U.S.: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.3.5.3. U.S.: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.3.5.4. U.S.: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.3.6. Animal Sedatives Market - Canada
9.3.6.1. Canada: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.3.6.2. Canada: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.3.6.3. Canada: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.3.6.4. Canada: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.4. Animal Sedatives Market - Europe
9.4.1. Europe: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.4.2. Europe: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.4.3. Europe: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.4.4. Europe: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.4.5. Animal Sedatives Market - UK
9.4.5.1. UK: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.4.5.2. UK: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.4.5.3. UK: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.4.5.4. UK: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.4.6. Animal Sedatives Market - France
9.4.6.1. France: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.4.6.2. France: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.4.6.3. France: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.4.6.4. France: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.4.7. Animal Sedatives Market - Germany
9.4.7.1. Germany: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.4.7.2. Germany: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.4.7.3. Germany: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.4.7.4. Germany: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.4.8. Animal Sedatives Market - Italy
9.4.8.1. Italy: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.4.8.2. Italy: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.4.8.3. Italy: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.4.8.4. Italy: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.4.9. Animal Sedatives Market - Spain
9.4.9.1. Spain: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.4.9.2. Spain: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.4.9.3. Spain: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.4.9.4. Spain: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.4.10. Animal Sedatives Market - Netherlands
9.4.10.1. Netherlands: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.4.10.2. Netherlands: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.4.10.3. Netherlands: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.4.10.4. Netherlands: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.4.11. Animal Sedatives Market - Russia
9.4.11.1. Russia: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.4.11.2. Russia.: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.4.11.3. Russia: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.4.11.4. Russia: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.5. Animal Sedatives Market - Asia Pacific
9.5.1. Asia Pacific: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.5.2. Asia Pacific: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.5.3. Asia Pacific: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.5.4. Asia Pacific: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.5.5. Animal Sedatives Market - China
9.5.5.1. China: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.5.5.2. China.: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.5.5.3. China: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.5.5.4. China: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.5.6. Animal Sedatives Market - India
9.5.6.1. India: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.5.6.2. India.: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.5.6.3. India: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.5.6.4. India: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.5.7. Animal Sedatives Market - Japan
9.5.7.1. Japan: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.5.7.2. Japan.: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.5.7.3. Japan: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.5.7.4. Japan: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.5.8. Animal Sedatives Market - Malaysia
9.5.8.1. Malaysia: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.5.8.2. Malaysia.: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.5.8.3. Malaysia: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.5.8.4. Malaysia: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.5.9. Animal Sedatives Market - Indonesia
9.5.9.1. Indonesia: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.5.9.2. Indonesia.: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.5.9.3. Indonesia: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.5.9.4. Indonesia: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.5.10. Animal Sedatives Market - South Korea
9.5.10.1. South Korea: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.5.10.2. South Korea.: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.5.10.3. South Korea: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.5.10.4. South Korea: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.6. Animal Sedatives Market - Middle East & Africa
9.6.1. Middle East & Africa: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.6.2. Middle East & Africa: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.6.3. Middle East & Africa: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.6.4. Middle East & Africa: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.6.5. Animal Sedatives Market - Saudi Arabia
9.6.5.1. Saudi Arabia: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.6.5.2. Saudi Arabia: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.6.5.3. Saudi Arabia: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.6.5.4. Saudi Arabia: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.6.6. Animal Sedatives Market - South Africa
9.6.6.1. South Africa: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.6.6.2. South Africa: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.6.6.3. South Africa: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.6.6.4. South Africa: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.6.7. Animal Sedatives Market - Israel
9.6.7.1. Israel: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.6.7.2. Israel: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.6.7.3. Israel: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.6.7.4. Israel: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.6.8. Animal Sedatives Market - UAE
9.6.8.1. UAE: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.6.8.2. UAE: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.6.8.3. UAE: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.6.8.4. UAE: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.7. Animal Sedatives Market - Latin America
9.7.1. Latin America: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.7.2. Latin America: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.7.3. Latin America: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.7.4. Latin America: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.7.5. Animal Sedatives Market - Mexico
9.7.5.1. Mexico: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.7.5.2. Mexico: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.7.5.3. Mexico: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.7.5.4. Mexico: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.7.6. Animal Sedatives Market - Brazil
9.7.6.1. Brazil: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.7.6.2. Brazil: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.7.6.3. Brazil: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.7.6.4. Brazil: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
9.7.7. Animal Sedatives Market - Argentina
9.7.7.1. Argentina: Animal Sedatives Market, by Route of Administration, 2019-2032 (USD Million)
9.7.7.2. Argentina: Animal Sedatives Market, by Animal Type, 2019-2032 (USD Million)
9.7.7.3. Argentina: Animal Sedatives Market, by Application, 2019-2032 (USD Million)
9.7.7.4. Argentina: Animal Sedatives Market, by Drug Class, 2019-2032 (USD Million)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. Aspen Pharmacare
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Bayer Animal Health
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. Bimeda Animal Health
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. Boehringer Ingelheim
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. Ceva Sante Animale
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. Chanelle Pharma
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Dechra Pharmaceuticals
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. Elanco Animal Health
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. Orion Corporation
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. Neogen Corporation
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Development
11.11. Norbrook Laboratories
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Benchmarking
11.11.4. Recent Development
11.12. Troy Laboratories
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Benchmarking
11.12.4. Recent Development
11.13. Vetoquinol
11.13.1. Company Overview
11.13.2. Financial Performance
11.13.3. Product Benchmarking
11.13.4. Recent Development
11.14. Virbac
11.14.1. Company Overview
11.14.2. Financial Performance
11.14.3. Product Benchmarking
11.14.4. Recent Development
11.15. Zoetis
11.15.1. Company Overview
11.15.2. Financial Performance
11.15.3. Product Benchmarking
11.15.4. Recent Development
°ü·ÃÀÚ·á